Loading...

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

BACKGROUND: BCG vaccination provides incomplete protection against tuberculosis in infants. A new vaccine, modified Vaccinia Ankara virus expressing antigen 85A (MVA85A), was designed to enhance the protective efficacy of BCG. We aimed to assess safety, immunogenicity, and efficacy of MVA85A against...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Lancet
Main Authors: Tameris, Michele D, Hatherill, Mark, Landry, Bernard S, Scriba, Thomas J, Snowden, Margaret Ann, Lockhart, Stephen, Shea, Jacqueline E, McClain, J Bruce, Hussey, Gregory D, Hanekom, Willem A, Mahomed, Hassan, McShane, Helen
Format: Artigo
Sprog:Inglês
Udgivet: Elsevier 2013
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5424647/
https://ncbi.nlm.nih.gov/pubmed/23391465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(13)60177-4
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!